Arcutis Biotherapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Arcutis Biotherapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ARQT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001787306
Board of directors
-
Amit Munshi · DirectorSince 2025
-
Bhaskar Chaudhuri · DirectorSince 2023
-
Christopher Peetz · DirectorSince 2026
-
Halley E. Gilbert · DirectorSince 2023
-
Howard G. Welgus · DirectorSince 2023
-
Keith R. Leonard · DirectorSince 2023
-
Neha Krishnamohan · DirectorSince 2023
-
Patrick J. Heron · DirectorSince 2023
-
Sue-Jean Lin · DirectorSince 2023
-
Terrie Curran · DirectorSince 2023
-
Todd Franklin Watanabe · Director · See RemarksSince 2023
Board connections
8 of this board's directors also sit on 11 other boards.
- via Christopher Peetz and Patrick J. Heron
- via Halley E. Gilbert
- via Amit Munshi
- via Amit Munshi
- via Keith R. Leonard
- via Patrick J. Heron
- via Terrie Curran
- via Sue-Jean Lin
- via Bhaskar Chaudhuri
- via Halley E. Gilbert
- via Amit Munshi
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $15,882,350
- 77 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Howard G. Welgus Director | Option exercise | +822 | $6.52 | $5,361 |
| Aug 17, 2026 | Howard G. Welgus Director | Option exercise | +1,019 | $7.51 | $7,653 |
| Aug 17, 2026 | Howard G. Welgus Director | Option exercise | +2,255 | $8.63 | $19,461 |
| Aug 17, 2026 | Howard G. Welgus Director | Open-market sale | −4,730 | $26.18 | $123,835 |
| Aug 12, 2026 | Burnett Patrick Officer (See Remarks) | Option exercise | +6,700 | $3.64 | $24,388 |
| Aug 12, 2026 | Burnett Patrick Officer (See Remarks) | Open-market sale | −6,700 | $26.08 | $174,767 |
| Aug 11, 2026 | Burnett Patrick Officer (See Remarks) | Option exercise | +8,300 | $3.64 | $30,212 |
| Aug 11, 2026 | Burnett Patrick Officer (See Remarks) | Open-market sale | −8,300 | $26.52 | $220,129 |
| Aug 3, 2026 | Todd Franklin Watanabe Director, Officer (See Remarks) | Open-market sale | −4,375 | $26.12 | $114,261 |
| Aug 3, 2026 | Matsuda Masaru Officer (See Remarks) | Open-market sale | −1,230 | $26.12 | $32,124 |
| Aug 3, 2026 | Burnett Patrick Officer (See Remarks) | Open-market sale | −955 | $26.12 | $24,942 |
| Jul 15, 2026 | Howard G. Welgus Director | Option exercise | +822 | $6.52 | $5,361 |
| Jul 15, 2026 | Christopher Peetz Director | Grant or award | +4,315 | — | — |
| Jul 15, 2026 | Howard G. Welgus Director | Option exercise | +1,019 | $7.51 | $7,653 |
| Jul 15, 2026 | Howard G. Welgus Director | Option exercise | +2,255 | $8.63 | $19,461 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.